glp-1 receptor agonist market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Size

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

GLP-1 RAs are used for managing blood glucose levels in people with type 2 diabetes mellitus and have also been licensed for use in weight loss treatment

This and other trials have shown improvements in patients lipid profiles with the most pronounced impact on reduction of triglycerides

Naturally optimize your appetite, cravings and metabolic efficiency for effortless weight loss without medications

For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity

The results of a Phase II clinical trial have demonstrated significant weight reduction in overweight and obese adults